We report a 31-year-old female who had repeated thrombosis and was diagnosed as having congenital homozygous protein C deficiency based on decreased protein C antigen and activity, and the findings of family history. This patient had shown no symptom of thrombosis until the age of 27 years, when she had cerebral infarction as the first symptom. Low molecular weight heparin was useful for disseminated intravascular coagulation (DIC) that complicated protein C deficiency in this patient. (Internal Medicine 31: 922-925, 1992) 
Introduction
Congenital protein C deficiency is a genetic disorder that predisposes to thrombosis and embolism (1) . We encountered a 31-year-old female who was diagnosed as having congenital homozygous protein C deficiency based on decreased protein C antigen and activity, and the findings obtained by the family history. Disseminated intravascular coagulation (DIC) was also diagnosed according to the diagnostic criteria of DIC proposed by the Research Group of the Ministry of Health and Welfare was treated with low molecular weight heparin (LMW heparin).
Case Report
A 31-year-old female was admitted to our hospital with repeated thromboses. She was well until the age of 27, when she developed disturbance of consciousness while riding a bicycle in 1986. In March 1988, she devel oped disturbance of consciousness followed by abnormal behavior during housework at the age of 30. Computed tomography (CT) scanning of the head showed cerebral infarction on the left temporal lobe. In the mid-June 1989, she was admitted to another hospital due to in creased abdominal pain, watery diarrhea, and vomiting and underwent an operation for necrosis in the sigmoid colon. On July 4, of the same year, left abdominal pain and mucoid bloody feces appeared, and she underwent an operation at this hospital under the diagnosis of thrombosis in the inferior mesenteric vein. On August 30, pain and swelling in the bilateral limbs developed, and venography of the lower limbs showed deep venous thrombosis peripheral to the thigh. Anti-platelet therapy and treatment with urokinase, heparin, and prosta glandin E1 (PGEi) improved the symptoms. Since such thrombosis frequently recurred, she was referred to our hospital on the suspicion of a congenital coagulation abnormality. In past illness, no abnormalities were detected at her birth and during growth. She had never taken contra ceptive pills. In 1986 (at the age of 27 years), she under went an operation for tubal rupture, but preoperative examination showed no abnormal findings. In familial history, her parents were second cousins (Fig. 1) . Her mother died of cerebral thrombosis at the age of 35 years, her paternal grandfather died of cerebrovascular disease (CVA), and her brother died immediately after birth. On admission, she was 150cm tall and weighed 67 kg. Her body temperature was 36.6°C. No anemia or jaun dice was observed. The chest was normal. In the abdomen, surgical wounds were present, but no tenderness or resistance was noted. The liver, spleen, and kidneys were not palpable. The lower limbs were swollen but showed no flare or tenderness. There were no neuro- Table 2 ). The plasma level of each coagulation factor was nearly normal. However, the fibrinogen and fibrin degradation product (FDP) level was 29.2 /ig/ml, and the D-dimer 24.9^g/ml (normal value 0-0.5^g/ml). FM test also showed a positive result. Regarding the factors inhibiting the coagulation, the antithrombin III (AT III) was 110% , but the protein C antigen level was less than 0.3 //g/ml by the one-step sandwich enzyme immunoassay using a monoclonal antibody which recognizes the Gla domain of protein C (Teijin, TD-82) (normal value 2.76-3.76/ig/ml) (2) and below the detection limit by Laurell's rocket immuno-electrophoresis (3). Protein C activity was less than 5%, which was determined by using protein C-deficient plasma and the protein C activator (4), but the protein S antigen was 110%. The decrease of platelet aggregation by collagen and arachi donic acid was probably due to the anti platelet drugs administered at the previous hospital. These findings suggested protein C deficiency and DIC. DIC was improved with treatment with AT III pre paration (1,500U) and LMW-heparin (5,000U/day). Warfarin (4mg/day) was used in combination with LMW-heparin to discontinue the latter. However, thrombin/antithrombin III complex (TAT), D-dimer and plasmin-O2 plasmin inhibitor complex (PIC) gradually increased, and flare, pain, and heat sensation appeared 3 days after the initiation of warfarin administration, and thrombophlebitis developed at upper limbs. Radio isotope fibrinogen uptake study revealed the develop ment of thrombi in the vein of upper limbs. Therefore, the dose ofwarfarin was reduced to 2 mg/day, and LMW heparin was continuously used. In addition, fresh frozen plasma (FFP) was administered. Thrombophlebitis im proved. At present, ticlopidine is used in combination with these drugs, and no symptoms of thrombosis have been observed.
Familial investigation
The protein C antigen and activity levels in family members who could be investigated are shown in Fig.  1 . Her father showed a protein C antigen level of 40% (Laurell's method) (3) and 1.8^g/ml (EIA) (2) , and a protein C activity of 44% (thrombin-activated assay) (4). The paternal and maternal uncles and aunts had no history of thrombosis but showed decreased protein C antigen and activity. The degree of the decrease was less marked in the maternal uncle and aunt.
Discussion
This patient developed transient disturbance of con sciousness while pedaling a bicycle at the age of 27 years, left temporal lobe infarction at 30 years, and thromboses in the inferior mesenteric vein and a deep vein in the lower limbs at the age of 31. Examinations to clarify the cause of this frequent thrombosis showed a protein C Internal Medicine Vol. 31, No. 7 (July 1992) APTT 41.3 s ELT 9.5 h PT 16.8 s FDP 29.2 ^g/ml TT 14,0% D-dimer 24. 9 ^g/ml Fibrinogen 83 mg/dl FM ( + ) Factor II 80% Plasminogen 87.6% Factor V 93% a2 PI 73.4% Factor VII 70% Bleeding time 3 min Factor VIII 68% Plat retention 39. 1% Factor IX 52% Plat aggregation Factor X 76% ADP 45% Factor XI 57% Adrenaline 1 1% Factor XII 57% PAF 59% PIVKA II <1% Arachid. A 0% AT III 110% RIPA 82% Protein C activity 5% Cardiolipin antibody antigen 0.3 /^g/ml IgG ( -) Protein S IgM (-) antigen 1 10% antigen level of less than 0.3fig (ElA) and below the detection limit (Laurell's method) ( Table 2) , and a pro tein C activity of less than 6% (coagulation method). These findings suggested protein C deficiency. This deficiency was considered to be the cause of the frequent thrombosis. In her family history, her mother died of cerebral thrombosis, and paternal grandfather died of CVA. In addition her father showed 40% (Laurell's method) and 1.8fig/ml (ElA) protein C antigen, and 44% in the activity of protein C (coagulation method). The paternal and maternal uncles and aunts had no history of thrombosis but showed decreased protein C antigen and activity. These results suggest that protein C deficiency in the proband was inherited from both paternal and maternal sides, i.e., homozygous. Homozygous protein C deficiency has been reported to develop during the neonatal period and to be a severe disease repeatedly inducing purpura fulminans (5, 6). However, Manabe and Matsuda reported a patient with homozygous protein C deficiency who showed no symptoms during the neonatal period but developed venous thrombosis at the age of 14 years (7). In the present patient, symptoms suggestive of thrombosis appeared at the age of 27 years, and a definite diagnosis was made at the age of 31 years. The patient reported by Manabe and Matsuda (7) and our patient suggest that homozygous protein C deficiency sometimes produces no symptoms during childhood. Repeated purpura fulminans has also been reported in heterozygous protein C deficiency and is not always specific to homozygous deficiency (8). The development of symptoms of protein C deficiency or abnormality may be affected by the degree of impairment of hemostatic homeostasis in the body caused by quantitative and qualitative protein C abnormalities. DIC complicating congenital protein C deficiency has been reported in patients with purpura fulminans who developed protein C deficiency during the neonatal period (5, 9-16). Our patient also showed on admission prolonged PT, decreased fibrinogen and increased FDP, fulfilling the criteria of DIC by the Research Group of the Ministry of Health and Welfare. LMW-heparin administration decreased TAT, D-dimer, and PIC. These results suggest the usefulness of LMW-heparin for DIC.
